This contract expires in 338 days (Sep 29, 2027).
DELOITTE CONSULTING LLP - DRUG SUPPLY CHAIN AND AI BUSINESS TRANSFORMATION INITIATIVES
Key Details
Description
DRUG SUPPLY CHAIN AND AI BUSINESS TRANSFORMATION INITIATIVES
Context & Analysis
On Sep 30, 2026, Department of Health and Human Services obligated $12,899,354.94 to DELOITTE CONSULTING LLP for drug supply chain and ai business transformation initiatives. The award is classified under NAICS 541611 — ADMINISTRATIVE MANAGEMENT AND GENERAL MANAGEMENT CONSULTING SERVICES. Performance is located in SILVER SPRING, MD. The contract is scheduled through Sep 29, 2027 — approximately 11 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541611 — related awards are listed below.
Market context
- Recompete outlook
- Ends Sep 29, 2027, in 11 months. Recompete signal as of Oct 26, 2026: 55/100, combining time to the end date, the incumbent's history with this agency, whether the award was competed, and its size.
- Competition
- Competition type not recorded. 81% of 902 awards in this market (Department of Health and Human Services awards in NAICS 541611 over the last 3 years) were competed; median 3 offers.
- Award size
- At $12.9M, this award is larger than three in four of the 1625 priced Department of Health and Human Services awards in NAICS 541611 over the last 3 years (median $700K).
- Incumbent at this agency
- DELOITTE CONSULTING LLP has 429 other awards from Department of Health and Human Services, totalling $6.1B, 2013–2026.
- Largest vendors in this market
By obligations, Department of Health and Human Services awards in NAICS 541611 over the last 3 years.
- GENERAL DYNAMICS CORP — 3 awards, $411.8M
- MAXIMUS INC — 7 awards, $358.4M
- RESEARCH TRIANGLE INSTITUTE — 46 awards, $326.3M
- BOOZ ALLEN HAMILTON HOLDING CORPORATION — 34 awards, $308.1M
- VERITAS CAPITAL FUND MANAGEMENT, L.L.C. — 25 awards, $228.4M
Computed from USAspending award data on Oct 26, 2026.
Contractor Information
Related Federal Investment
Similar Awards
IGF::OT::IGF-PPHF-2013-ELIGIBILITY SUPPORT
SERCO INC
$1.2B
IGF::OT::IGF FOR OTHER FUNCTIONS
HIGHPOINT DIGITAL, INC.
$839.9M
IGF::OT::IGF CCIIO ENROLLMENT RESOLUTION AND RECONCILIATION, FORM 1095-A DATA REPORTING TASK ORDER
COGNOSANTE, LLC
$315.5M
IGF::OT::IGF ELIGIBILITY APPEALS OPERATIONS SUPPORT
MAXIMUS FEDERAL SERVICES, INC.
$286.9M
IGF::OT::IGF THE CERT PROGRAM CALCULATES BI-ANNUAL IMPROPER PAYMENT RATES BASED ON THE RESULTS OF THE REVIEWS CONDUCTED. THESE RATES INCLUDE AN OVERALL NATIONAL MEDICARE FFS IMPROPER PAYMENT RATE AND IMPROPER PAYMENT RATES FOR EACH CLAIM TYPE [PART A INPATIENT HOSPITAL PROSPECTIVE PAYMENT SYSTEM (PPS); PART A EXCLUDING INPATIENT HOSPITAL PPS; PART B; AND DURABLE MEDICAL EQUIPMENT, PROSTHETICS, ORTHOTICS, AND SUPPLIES (DMEPOS)]. THE CERT PROGRAM ENSURES A STATISTICALLY VALID RANDOM SAMPLE; THEREFORE, THE IMPROPER PAYMENT RATE CALCULATED FROM THIS SAMPLE IS CONSIDERED TO BE REFLECTIVE OF ALL OF CLAIMS PROCESSED BY MEDICARE FFS PROGRAM DURING THE REPORT PERIOD. CMS ALSO USES THE CERT PROGRAM TO PERFORM SPECIAL STUDIES AND SUPPLEMENTAL MEASUREMENTS TO DETERMINE THE IMPROPER PAYMENT RATES OF PARTICULAR CLAIM TYPES. CALCULATIONS OF THESE RATES FACILITATE CMS ABILITY TO TAKE APPROPRIATE CORRECTIVE ACTIONS TO REDUCE IMPROPER PAYMENTS.
EMPOWER AI, INC.
$230.2M
Stay Updated
Get notified about new opportunities matching your interests.